PMID,Title,Publication Date,Company Authors
40066659,Inhibition of HDAC4 in granulosa cells improved co-cultured oocyte maturation in vitro independent of LH in porcine.,2025 Mar 11,"Zuo Zhenzi (State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China.; State Key Laboratory of Cancer Biology and Department of Physiology and Pathophysiology, Fourth Military Medical University, Xi'an, China.); Bao Yibing (State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China.); Lin Lin (State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China.); Li Hengxing (State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China.); Wang Tengteng (State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China.); Xia Guoliang (State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China.); Wang Chao (State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China.)"
40066656,Socioeconomic Disparities in Prostate Cancer Treatment: The Impact of Area Deprivation Index on Initial Treatment Type for Localized PCa in a North-American Cohort.,2025 Mar 11,"Vigan√≤ Silvia (VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Department of Human and Pediatric Pathology Gaetano Barresi, Section of Urology, Messina, Italy.); Finati Marco (VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy.); Stephens Alex (Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA.); Bertini Alessandro (VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.); Finocchiaro Alessio (VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.); Salonia Andrea (Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.); Briganti Alberto (Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.); Montorsi Francesco (Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.); Rossanese Marta (Department of Human and Pediatric Pathology Gaetano Barresi, Section of Urology, Messina, Italy.); Ficarra Vincenzo (Department of Human and Pediatric Pathology Gaetano Barresi, Section of Urology, Messina, Italy.); Sood Akshay (Department of Urology, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.); Rogers Craig (VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.); Abdollah Firas (VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.)"
